Changzheng Li

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao, Nong Xu, Ziyu Li et al. · The Lancet Oncology · 2023 · 171 citations

Oncology, Medicine, Advanced Solid Tumours +8

Sphingosine kinase 1 promotes liver fibrosis by preventing miR‐19b‐3p‐mediated inhibition of CCR2

Tian Lan, Changzheng Li, Guizhi Yang et al. · Hepatology · 2018 · 153 citations · Full text

Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway

Xiaoqian Ji, Changzheng Li, Yitao Ou et al. · Molecular and Cellular Endocrinology · 2016 · 107 citations

Renal Inflammation, Oxidative Stress, Inflammation +17

Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2α axis

Changzheng Li, Binghuo Wu, Yishan Li et al. · Cell stem cell · 2022 · 84 citations

Developmental Biology, Cell Regulation, Gcn2-eif2α Axis +8

Treatment of gastric varices by endoscopic sclerotherapy using butyl cyanoacrylate: 10 yearsʼ experience of 635 cases

Liu–Fang Cheng, Zhiqiang Wang, Changzheng Li et al. · Chinese Medical Journal · 2007 · 74 citations · Full text